Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma

Published:2017-08 Issue:2 Volume:67 Page:293-301
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Huang Ao,Zhao Xin,Yang Xin-Rong,Li Fu-Qiang,Zhou Xin-Lan,Wu Kui,Zhang Xin,Sun Qi-Man,Cao Ya,Zhu Hong-Mei,Wang Xiang-Dong,Yang Huan-Ming,Wang Jian,Tang Zhao-You,Hou Yong,Fan Jia,Zhou Jian

Publisher

Elsevier BV

Subject

Hepatology

Reference54 articles.

1. A new initiative on precision medicine;Collins;N Engl J Med,2015

2. NCI-MATCH launch highlights new trial design in precision-medicine era;McNeil;J Natl Cancer Inst,2015

3. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2016

4. Genetic landscape and biomarkers of hepatocellular carcinoma;Zucman-Rossi;Gastroenterology,2015

5. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution;McGranahan;Cancer Cell,2015

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts;Molecular Cancer;2024-08-02

2. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments;Gut;2024-07-25

3. Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers;ACS Biomaterials Science & Engineering;2024-07-01

4. Construction of a TP53 mutation-associated ceRNA network as prognostic biomarkers in hepatocellular carcinoma;Heliyon;2024-05

5. Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma;Journal of Personalized Medicine;2024-04-15